EBA
CRL icon

Eagle Bay Advisors’s Charles River Laboratories CRL Stock Holding History

Eagle Bay Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-428
Closed -$79K – 299
2024
Q4 		$79K Sell
428
-105
-20% -$20.2K 0.05% 255
2024
Q3 		$105K Sell
533
-75
-12% -$15.6K 0.04% 274
2024
Q2 		$126K Sell
608
-39
-6% -$8.84K 0.08% 180
2024
Q1 		$175K Sell
647
-158
-20% -$37.7K 0.11% 140
2023
Q4 		$190K Sell
805
-40
-5% -$7.87K 0.12% 141
2023
Q3 		$166K Buy
845
+179
+27% +$36.7K 0.08% 165
2023
Q2 		$140K Sell
666
-114
-15% -$22.7K 0.08% 159
2023
Q1 		$157K Sell
780
-55
-7% -$12.5K 0.09% 154
2022
Q4 		$182K Buy
835
+550
+193% +$120K 0.1% 145
2022
Q3 		$57K Sell
285
-348
-55% -$75.1K 0.04% 315
2022
Q2 		$135K Buy
633
+478
+308% +$117K 0.08% 163
2022
Q1 		$44K Sell
155
-158
-50% -$48.7K 0.04% 151
2021
Q4 		$118K Buy
313
+48
+18% +$18.6K 0.08% 154
2021
Q3 		$108K Sell
265
-82
-24% -$34.1K 0.06% 221
2021
Q2 		$130K Buy
+347
New +$116K 0.1% 123

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eagle Bay Advisors's CRL Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 428 shares — an estimated $79K sold.

Eagle Bay Advisors first reported a position in CRL in Q2 2021 and held it in 15 quarters. The position peaked at $190K in Q4 2023. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 428 Charles River Laboratories shares in Q1 2025, an estimated $79K.
  • Eagle Bay Advisors first reported a position in Charles River Laboratories in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Charles River Laboratories position peaked at $190K in Q4 2023.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.